temozolomide has been researched along with curcumin in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.26) | 29.6817 |
2010's | 14 (73.68) | 24.3611 |
2020's | 4 (21.05) | 2.80 |
Authors | Studies |
---|---|
Chen, CC; D'Andrea, A; Taniguchi, T | 1 |
Escalon, E; Melnick, SJ; Nair, SM; Ramachandran, C | 1 |
Dilnawaz, F; Sahoo, SK | 1 |
Bandey, I; Chiou, SH; Huang, AP; Tsai, JC; Tu, PH | 1 |
Hu, X; Shao, J; Wang, L; Wen, C; Yin, H; You, C; Zhang, W; Zhou, C; Zhou, Y | 1 |
Beveridge, RD; Carroll, TA; Collis, SJ; Cox, A; Depondt, ML; Fernando, M; Jellinek, D; Kriplani, DH; Myers, KN; Patil, AA; Roylance, A; Sayal, P | 1 |
Battastini, AM; Bishop, AJR; Braganhol, E; Bristot, IJ; Figueiró, F; Forcelini, CM; Gelain, DP; Klafke, K; Moreira, JCF; Morrone, M; Paludo, FJ; Terra, SR; Zanotto-Filho, A | 1 |
Fei, X; Shi, L; Wang, Z | 1 |
Cai, T; Chen, YD; Liu, Q; Wang, ZF; Wu, H | 1 |
Shi, L; Sun, G | 2 |
Akasov, R; Burov, S; Chiper, M; Dontenwill, M; Leko, M; Markvicheva, E; Vandamme, T; Zaytseva-Zotova, D | 1 |
Chen, CC; Huang, BR; Kao, JY; Lai, SW; Lin, HY; Liu, YS; Lu, DY; Tsai, CH; Way, TD | 1 |
Bagherian, A; Banfshe, HR; Davoodvandi, A; Ghaderi, A; Hamblin, MR; Mardani, R; Mirzaei, H; Roudi, B; Shamollaghamsari, S; Taghizadeh, M | 1 |
Ali Ahmad, K; Ali Khan, B; Almoshari, Y; Hadi Sultan, M; Iqbal, H; Khan, MK; Razzaq, A; Saeed Alqahtani, S | 1 |
Beltzig, L; Christmann, M; Kaina, B | 1 |
Hadjighassem, M; Hamblin, MR; Hosseindoost, S; Jafari, A; Mahdian, SMA; Mirzaei, H; Mousavi, SM; Ostadian, A; Rajabi, A; Vousooghi, N | 1 |
Cao, P; Li, XM; Liang, GB; Liu, Y; Luo, LH; Xu, YH; Zhu, TZ | 1 |
Escalon, E; Lollett, IV; Melnick, SJ; Quirin, KW; Ramachandran, C | 1 |
19 other study(ies) available for temozolomide and curcumin
Article | Year |
---|---|
The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cell Line, Tumor; Curcumin; Dacarbazine; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fanconi Anemia Complementation Group D2 Protein; Fanconi Anemia Complementation Group F Protein; Fanconi Anemia Complementation Group Proteins; Glioma; Guanine; Humans; Protein Processing, Post-Translational; RNA Interference; RNA, Small Interfering; Temozolomide; Time Factors; Transfection; Tumor Suppressor Proteins; Ubiquitins | 2007 |
Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Curcuma; Curcumin; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Glioblastoma; Humans; Inhibitory Concentration 50; Medulloblastoma; Phytotherapy; Plant Extracts; Plants, Medicinal; Rhizome; Temozolomide | 2012 |
Enhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model.
Topics: Acridine Orange; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Culture Techniques; Cell Death; Cell Line, Tumor; Curcumin; Dacarbazine; Drug Delivery Systems; Drug Synergism; Glioblastoma; Humans; Magnetics; Nanoparticles; Propidium; Staining and Labeling; Temozolomide | 2013 |
Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cell Movement; Cell Proliferation; Curcumin; Dacarbazine; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Female; Glioblastoma; Humans; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neoplastic Stem Cells; Progranulins; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; RNA Interference; RNA, Small Interfering; Temozolomide; Transcription Factor AP-1; Transcription Factors; Tumor Cells, Cultured | 2015 |
Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Curcumin; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Humans; Mice; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Temozolomide; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2014 |
FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cell Line, Tumor; Curcumin; Dacarbazine; Fanconi Anemia; Fanconi Anemia Complementation Group D2 Protein; Glioma; Humans; Neoplasm Grading; Temozolomide | 2014 |
Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas.
Topics: Animals; Apoptosis; Autophagy; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Curcumin; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Glioblastoma; Humans; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Rats; Temozolomide | 2015 |
Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells.
Topics: Apoptosis; Caspase 3; Cell Proliferation; Curcumin; Dacarbazine; Diarylheptanoids; Glioblastoma; Humans; Neoplastic Stem Cells; Primary Cell Culture; Reactive Oxygen Species; Signal Transduction; Temozolomide | 2015 |
Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Curcumin; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; MicroRNAs; NF-kappa B; Signal Transduction; Temozolomide | 2015 |
Low-Dose DMC Significantly Enhances the Effect of TMZ on Glioma Cells by Targeting Multiple Signaling Pathways Both In Vivo and In Vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Cell Line, Tumor; Curcumin; Dacarbazine; Diarylheptanoids; Drug Synergism; G1 Phase; Glioblastoma; Humans; Janus Kinases; Mice; Mice, Nude; Neoplasm Proteins; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Temozolomide; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2015 |
Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro.
Topics: Antineoplastic Agents; Cell Culture Techniques; Cell Line, Tumor; Chemistry, Pharmaceutical; Curcumin; Dacarbazine; Doxorubicin; Drug Screening Assays, Antitumor; HCT116 Cells; Hep G2 Cells; Humans; MCF-7 Cells; Oligopeptides; Peptides, Cyclic; Spheroids, Cellular; Temozolomide | 2016 |
DMC is not better than TMZ on intracranial anti-glioma effects.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Proliferation; Curcumin; Diarylheptanoids; Glioma; Humans; Male; Mice; Mice, Nude; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Curcumin Promotes Connexin 43 Degradation and Temozolomide-Induced Apoptosis in Glioblastoma Cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Connexin 43; Curcumin; Glioblastoma; Humans; Proteolysis; Stimulation, Chemical; Temozolomide; Tumor Cells, Cultured | 2019 |
Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Curcumin; Drug Synergism; Glioblastoma; Humans; Temozolomide; Wnt Signaling Pathway | 2020 |
Development of nanocubosomes co-loaded with dual anticancer agents curcumin and temozolomide for effective Colon cancer therapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Curcumin; Drug Carriers; Drug Liberation; Humans; Nanoparticles; Particle Size; Serum Albumin, Bovine; Temozolomide | 2022 |
Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics.
Topics: Artesunate; Cellular Senescence; Curcumin; Glioblastoma; Humans; Lomustine; Neoplasm Recurrence, Local; NF-kappa B; Poly(ADP-ribose) Polymerase Inhibitors; Senotherapeutics; Temozolomide | 2022 |
Exosomes released from U87 glioma cells treated with curcumin and/or temozolomide produce apoptosis in naive U87 cells.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Curcumin; Drug Resistance, Neoplasm; Exosomes; Glioblastoma; Glioma; HSP27 Heat-Shock Proteins; Temozolomide; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2023 |
β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Curcuma; Dacarbazine; Down-Regulation; Drug Resistance, Neoplasm; Flavonoids; Glia Maturation Factor; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Sesquiterpenes; Survivin; Temozolomide | 2014 |
Anticancer potential and mechanism of action of mango ginger (Curcuma amada Roxb.) supercritical CO₂ extract in human glioblastoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carbon Dioxide; Cell Line, Tumor; Cell Survival; Curcuma; Dacarbazine; Etoposide; Glioblastoma; Humans; Mice; Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction; Temozolomide | 2015 |